<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> arise at distinct stages of cellular development and maturation, potentially influencing antigen (Ag) presentation and T-cell recognition </plain></SENT>
<SENT sid="1" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is a highly malignant B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> associated with Epstein-Barr Virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> can be effectively treated in adults and children, leading to high survival rates, its ability to mask itself from the immune system makes <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> an intriguing disease to study </plain></SENT>
<SENT sid="3" pm="."><plain>In this paper, we will provide an overview of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and its association with EBV and the c-myc oncogene </plain></SENT>
<SENT sid="4" pm="."><plain>The contributions of EBV and c-myc to B-cell transformation, proliferation, or attenuation of cellular network and immune recognition or evasion will be summarized </plain></SENT>
<SENT sid="5" pm="."><plain>We will also discuss the various pathways by which <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> escapes immune detection by inhibiting both HLA class I- and II-mediated Ag presentation to T cells </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, we will provide an overview of recent developments suggesting the existence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-associated inhibitory molecules that may block HLA class II-mediated Ag presentation to CD4+ T cells, facilitating immune escape of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>